A Phase II Study of Fractionated Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors
Interventional
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Response rate to SBRT
3-6 Months
No
Robert Nordal, M.D.
Principal Investigator
Tom Baker Cancer Centre
Canada: Ethics Review Committee
18740
NCT00691691
November 2007
Name | Location |
---|